2023 Q2 Form 10-Q Financial Statement

#000101738623000182 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $50.00K $50.00K $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $0.00 $4.510K $2.010K
YoY Change -100.0% -18.88% -78.91%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $0.00 $4.510K $2.010K
YoY Change -100.0% -18.88% -78.91%
Operating Profit $45.49K $45.49K
YoY Change -2084.77% -918.77%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $45.49K $45.49K -$2.010K
YoY Change -2084.77% -918.18% -117.25%
Income Tax $0.00
% Of Pretax Income
Net Earnings $45.49K $45.49K -$2.010K
YoY Change -2084.77% -918.18% -117.25%
Net Earnings / Revenue 90.98% 90.98%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 6.000M shares 6.000M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $13.63K $18.13K
YoY Change -53.92% -43.18% -38.65%
Cash & Equivalents $12.43K $13.63K $18.13K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $75.00K $50.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $90.00K $63.63K $18.13K
YoY Change 314.78% 165.21% -38.62%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $740.0K $742.0K $742.0K
YoY Change -0.27% 0.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $739.4K $742.0K $742.0K
YoY Change -0.35% 0.0% 0.0%
TOTAL ASSETS
Total Short-Term Assets $90.00K $63.63K $18.13K
Total Long-Term Assets $739.4K $742.0K $742.0K
Total Assets $829.4K $805.6K $760.1K
YoY Change 8.61% 5.17% -1.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $0.00 $0.00 $0.00
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$110.0K -$133.8K -$179.3K
YoY Change -37.41% 6.8%
Common Stock $3.000K $3.000K $3.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $829.4K $805.6K $760.1K
YoY Change
Total Liabilities & Shareholders Equity $829.4K $805.6K $760.1K
YoY Change 8.61% 5.17% -1.48%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $45.49K $45.49K -$2.010K
YoY Change -2084.77% -918.18% -117.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.00K -$4.509K -$2.010K
YoY Change 336.68% -18.9% -117.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -10.00K -$4.509K -2.010K
Cash From Investing Activities
Cash From Financing Activities 0.000
Net Change In Cash -10.00K -$4.509K -2.010K
YoY Change 336.68% -18.9% -117.25%
FREE CASH FLOW
Cash From Operating Activities -$10.00K -$4.509K -$2.010K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18134 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
63625 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
18134 usd
CY2023Q1 vnja Land Held For Investment
LandHeldForInvestment
742000 usd
CY2022Q4 vnja Land Held For Investment
LandHeldForInvestment
742000 usd
CY2023Q1 us-gaap Assets
Assets
805625 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001532383
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-179302
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Vanjia Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3051284
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Unit 199
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Sugar Land
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77479-3121
CY2023Q1 dei City Area Code
CityAreaCode
832
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
289-3219
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6000000 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13625 usd
CY2022Q4 us-gaap Assets
Assets
760134 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9999999999 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9999999999 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8888888888 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8888888888 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
936400 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
936400 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133775 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179266 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
805625 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
760134 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
805625 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
760134 usd
CY2023Q1 us-gaap Revenues
Revenues
50000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4509 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5556 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
45491 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5556 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
45491 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5556 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
45491 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5556 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
30000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
30000000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4509 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5556 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4509 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5556 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5556 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18134 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29546 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13625 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23990 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
771547 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5556 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
765990 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
760134 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
45491 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
805625 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_842_eus-gaap--NatureOfOperations_zBniqQeROeqi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b>ORGANIZATION AND NATURE OF BUSINESS</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">Vanjia Corporation (formerly Vantone Realty Corporation) , (the “Company”), was incorporated on August 19, 2011 in the State of Texas. The company has conducted limited business operations since its inception. The Company's business plan is to build affordable homes in Houston, Texas. In 2018, the Company has begun a business to enroll students for real estate licensing courses. The Company’s year-end is December 31. </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zJUM4AxqI137" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white"><b>USE OF ESTIMATES</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"> </p>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_z1Wahif1cX69" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white"><b>CONCENTRATION OF CREDIT RISK</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">The Company's financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and related party payables it will likely incur in the near future. The Company places its cash with financial institutions of high credit worthiness. At times, its cash balance with a particular financial institution may exceed any applicable government insurance limits. The Company's management plans to assess the financial strength and credit worthiness of any parties to which it extends funds and as such, it believes that any associated credit risk exposures are limited. </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
133775 usd
CY2023Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
5000000 usd
CY2023Q1 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0 pure
CY2023Q1 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 usd
CY2022Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 usd

Files In Submission

Name View Source Status
0001017386-23-000182-index-headers.html Edgar Link pending
0001017386-23-000182-index.html Edgar Link pending
0001017386-23-000182.txt Edgar Link pending
0001017386-23-000182-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vnja-20230331.xsd Edgar Link pending
vnja_2023mar31-10q.htm Edgar Link pending
vnja-20230331_def.xml Edgar Link unprocessable
vnja-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
vnja-20230331_lab.xml Edgar Link unprocessable
vnja-20230331_pre.xml Edgar Link unprocessable
vnja_2023mar31-10q_htm.xml Edgar Link completed